About Alcohol dehydrogenase class-3
Alcohol dehydrogenase class-3 (ADH5) is a protein
from Homo sapiens identified by UniProt accession
P11766, 374 residues long.
MolForge cross-references it against 0 known binders and
153 disease associations.
Target properties
| Protein name | Alcohol dehydrogenase class-3 |
| UniProt accession | P11766 |
| Gene | ADH5 |
| Organism | Homo sapiens |
| Length | 374 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (153)
Diseases linked to this target (Open Targets).
- AMED syndrome, digenic · score 0.56
- blood protein measurement · score 0.35
- sex hormone-binding globulin measurement · score 0.33
- testosterone measurement · score 0.33
- aspartate aminotransferase measurement · score 0.32
- alcohol consumption measurement · score 0.29
- neuroinflammatory disorder · score 0.22
- high density lipoprotein cholesterol measurement · score 0.21
- Microcephaly · score 0.18
- Intellectual disability · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P11766-F1 | alphafold | PREDICTED | 98.09 | — |
Amino-acid sequence (374 residues)
MANEVIKCKA AVAWEAGKPL SIEEIEVAPP KAHEVRIKII ATAVCHTDAY TLSGADPEGC FPVILGHEGA GIVESVGEGV TKLKAGDTVI PLYIPQCGEC KFCLNPKTNL CQKIRVTQGK GLMPDGTSRF TCKGKTILHY MGTSTFSEYT VVADISVAKI DPLAPLDKVC LLGCGISTGY GAAVNTAKLE PGSVCAVFGL GGVGLAVIMG CKVAGASRII GVDINKDKFA RAKEFGATEC INPQDFSKPI QEVLIEMTDG GVDYSFECIG NVKVMRAALE ACHKGWGVSV VVGVAASGEE IATRPFQLVT GRTWKGTAFG GWKSVESVPK LVSEYMSKKI KVDEFVTHNL SFDEINKAFE LMHSGKSIRT VVKI
Explore Alcohol dehydrogenase class-3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets